Sai Life Sciences Limited
SAILIFE.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$315.86B
Close$
$662.42
53.7% downside
Current Fair Value
53.7% downsideOvervalued by 53.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $315.86 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $16.63 |
| Beta | 0.39 |
| Outstanding Shares | 211,806,358 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 86.66 |
|---|---|
| PEG | 408.33 |
| Price to Sales | 13.51 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$3.60
Average shareholder expectationRevenue Estimate
$5.71 B
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$3.97
Average shareholder expectationRevenue Estimate
$5.92 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Sai Life Sciences Limited
5,224 employees
CEO: Krishnam Raju Kanumuri Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development servi...